Traphagen Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis US Equity ETF
AVUS
|
+$83.2M |
| 2 |
Fidelity MSCI Utilities Index ETF
FUTY
|
+$42.4M |
| 3 |
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
|
+$26.5M |
| 4 |
Goldman Sachs Innovate Equity ETF
GINN
|
+$22.8M |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$4.96B |
| 2 |
Automatic Data Processing
ADP
|
+$259M |
| 3 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
+$110M |
| 4 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$84.4M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.58% |
| 2 | Technology | 3.11% |
| 3 | Healthcare | 1.35% |
| 4 | Consumer Staples | 1% |
| 5 | Consumer Discretionary | 0.99% |
Similar funds
Traphagen Investment Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Traphagen Investment Advisors held 175 positions worth $789M, up 2.4% from $771M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Traphagen Investment Advisors withdrew a net $5.21B in Q3 2023, closing 12 positions and reducing 51 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $9.21M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Traphagen Investment Advisors opened a new position in Avantis US Equity ETF worth $80.3M.
- Traphagen Investment Advisors's largest Q3 2023 buy was Avantis US Equity ETF: 1,095,600 shares worth $80.3M.
- Traphagen Investment Advisors added most to Goldman Sachs Access Investment Grade Corporate Bond ETF in Q3 2023, an estimated $26.5M increase.
- Traphagen Investment Advisors's biggest Q3 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $4.96B.
- Traphagen Investment Advisors fully exited VanEck Biotech ETF in Q3 2023, selling an estimated $9.21M.
- Traphagen Investment Advisors's ten largest holdings make up 69% of its $789M portfolio in Q3 2023.
- Traphagen Investment Advisors opened 21 new positions and closed 12 in Q3 2023.
- Traphagen Investment Advisors's portfolio value rose 2.4% quarter-over-quarter to $789M.
Based on Traphagen Investment Advisors's 13F filing for Q3 2023, filed 17 Jun 2024.